Milestone Pharmaceuticals Stock Price Prediction
| MIST Stock | USD 1.84 0.01 0.54% |
Oversold Vs Overbought
80
Oversold | Overbought |
EPS Estimate Next Quarter (0.17) | EPS Estimate Current Year (0.61) | EPS Estimate Next Year (0.81) | Wall Street Target Price 13 | EPS Estimate Current Quarter (0.16) |
Using Milestone Pharmaceuticals hype-based prediction, you can estimate the value of Milestone Pharmaceuticals from the perspective of Milestone Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Milestone Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Milestone because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Milestone Pharmaceuticals after-hype prediction price | USD 1.84 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Milestone |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Milestone Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Milestone Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Milestone Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Milestone Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Milestone Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Milestone Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Milestone Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Milestone Pharmaceuticals' historical news coverage. Milestone Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.09 and 4.79, respectively. We have considered Milestone Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Milestone Pharmaceuticals is slightly risky at this time. Analysis and calculation of next after-hype price of Milestone Pharmaceuticals is based on 3 months time horizon.
Milestone Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Milestone Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Milestone Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Milestone Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.39 | 2.95 | 0.00 | 0.04 | 6 Events / Month | 14 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.84 | 1.84 | 0.00 |
|
Milestone Pharmaceuticals Hype Timeline
Milestone Pharmaceuticals is now traded for 1.84. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.04. Milestone is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.39%. %. The volatility of related hype on Milestone Pharmaceuticals is about 2854.84%, with the expected price after the next announcement by competition of 1.88. About 57.0% of the company shares are owned by institutional investors. The book value of Milestone Pharmaceuticals was now reported as 0.39. The company recorded a loss per share of 0.8. Milestone Pharmaceuticals had not issued any dividends in recent years. The entity had 1-1 split on the 24th of March 2020. Given the investment horizon of 90 days the next projected press release will be in about 6 days. Check out Milestone Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Milestone Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Milestone Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Milestone Pharmaceuticals' future price movements. Getting to know how Milestone Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Milestone Pharmaceuticals may potentially react to the hype associated with one of its peers.
Milestone Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Milestone price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Milestone using various technical indicators. When you analyze Milestone charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Milestone Pharmaceuticals Predictive Indicators
The successful prediction of Milestone Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Milestone Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Milestone Pharmaceuticals based on analysis of Milestone Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Milestone Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Milestone Pharmaceuticals's related companies. | 2022 | 2023 | 2024 (projected) | Graham Number | 6.88 | 3.49 | 3.32 | Receivables Turnover | 4.12 | 0.26 | 0.25 |
Story Coverage note for Milestone Pharmaceuticals
The number of cover stories for Milestone Pharmaceuticals depends on current market conditions and Milestone Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Milestone Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Milestone Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Milestone Pharmaceuticals Short Properties
Milestone Pharmaceuticals' future price predictability will typically decrease when Milestone Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Milestone Pharmaceuticals often depends not only on the future outlook of the potential Milestone Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Milestone Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 43 M | |
| Cash And Short Term Investments | 66 M |
Additional Tools for Milestone Stock Analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.